Robert Weigle

Robert Weigle has a diverse work experience in various leadership roles within the medical and healthcare industry. Robert is currently the CEO of NOWDiagnostics | NOWDx since April 2023. Robert also serves as a Board Member at Tenon Medical, Inc. since May 2022. Previously, they held the position of Chief Executive Officer at Prime Genomics from October 2020 to the present. Robert was also the Chief Executive Officer at AEENA DX from April 2022 to March 2023. Additionally, they worked as an Executive in Residence at DigitalDx Ventures from August 2020 to October 2020, where they focused on investing in companies utilizing artificial intelligence and big data in the healthcare sector. Prior to that, they served as the CEO of Benvenue Medical from May 2009 to August 2020. Robert also served as a Member of the Board at Zyga from December 2013 to September 2017, and as the Vice President of Sales, Marketing, and Reimbursement at THEROX from an unspecified date in 2001 to April 2009.

Robert Weigle attended the University of California, Berkeley from 1979 to 1983. No specific degree or field of study is provided. Additionally, their attendance at Rio is mentioned, but no further details regarding the time frame or degree earned are given.